Annexon Newsroom

A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $12 to $30

Futu NewsDec 17 21:00 · Ratings

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 17 05:05

Annexon Biosciences' ANX005: Strong Buy Rating Backed by Promising Efficacy and Sales Potential

TipRanksDec 17 03:25 · Ratings

Annexon Announces Positive Topline Results From Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)

GlobeNewswireDec 16 20:30

Express News | Annexon Announces Positive Topline Results From Real-World Evidence Study Comparing Anx005 Treatment to Intravenous Immunoglobulin (Ivig) or Plasma Exchange (Pe) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (Gbs)

BreakingsDec 16 20:30

Annexon Insider Buyers Pleased With US$571k Return On Investment

Simply Wall StDec 13 18:06

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors With ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting

GlobeNewswireDec 5 21:00

Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)

TipRanksNov 21 20:11 · Ratings

Express News | Annexon Inc : JP Morgan Cuts Target Price to $9 From $11

BreakingsNov 20 13:28

Express News | Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

BreakingsNov 16 05:59

Cantor Fitzgerald Reiterates Overweight on Annexon

BenzingaNov 15 22:56

H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30

Futu NewsNov 15 21:35 · Ratings

A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30

Futu NewsNov 15 21:00 · Ratings

Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow JonesNov 15 19:46 · Ratings

Annexon Analyst Ratings

BenzingaNov 15 17:29 · Ratings

Annexon | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:16 · Announcements

Annexon Biosciences: Buy Rating Backed by Promising Data Releases and Strategic Long-term Potential

TipRanksNov 15 05:15 · Ratings

Annexon | 8-K: Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

SECNov 15 05:13

Express News | Annexon: Topline Data Expected Second Half 2026

BreakingsNov 14 21:06

Express News | Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

BreakingsNov 14 21:00